CoreCap Advisors LLC Invests $333,000 in SPDR S&P China ETF (NYSEARCA:GXC)

CoreCap Advisors LLC bought a new stake in SPDR S&P China ETF (NYSEARCA:GXC) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 4,862 shares of the company’s stock, valued at approximately $333,000. CoreCap Advisors LLC owned about 0.07% of SPDR S&P China ETF as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of GXC. OLD Mission Capital LLC acquired a new position in shares of SPDR S&P China ETF during the 1st quarter worth about $19,916,000. Syon Capital LLC bought a new position in SPDR S&P China ETF in the fourth quarter valued at approximately $13,227,000. Jane Street Group LLC increased its position in shares of SPDR S&P China ETF by 327.5% during the 1st quarter. Jane Street Group LLC now owns 190,015 shares of the company’s stock worth $12,499,000 after purchasing an additional 145,562 shares during the last quarter. Osborne Partners Capital Management LLC raised its stake in shares of SPDR S&P China ETF by 19.7% during the 1st quarter. Osborne Partners Capital Management LLC now owns 182,184 shares of the company’s stock worth $11,984,000 after purchasing an additional 29,959 shares in the last quarter. Finally, Executive Wealth Group LLC boosted its holdings in shares of SPDR S&P China ETF by 200.0% in the 1st quarter. Executive Wealth Group LLC now owns 141,287 shares of the company’s stock valued at $9,013,000 after buying an additional 94,190 shares during the last quarter.

SPDR S&P China ETF Trading Up 0.3 %

Shares of GXC opened at $65.52 on Friday. The company’s fifty day simple moving average is $67.27 and its 200 day simple moving average is $68.58. SPDR S&P China ETF has a 1-year low of $59.45 and a 1-year high of $77.33. The company has a market cap of $435.71 million, a price-to-earnings ratio of 9.52 and a beta of 0.84.

SPDR S&P China ETF Company Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.